Cameron John Reynolds - Jan 29, 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: President and CEO, Director
Signature: /s/ Cameron John Reynolds
Stock symbol: VNRX
Transactions as of: Jan 29, 2025
Transactions value $: $0
Form type: 4
Date filed: 1/31/2025, 04:05 PM
Previous filing: Dec 10, 2024
Next filing: Mar 27, 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VNRX	Stock Option (Right to Buy)	Disposed to Issuer		-50K	-100%		0	Jan 29, 2025	Common Stock	50K	$3.25	Direct	F1
transaction	VNRX	Stock Option (Right to Buy)	Award		+50K			50K	Jan 29, 2025	Common Stock	50K	$3.25	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on February 11, 2019, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on February 11, 2029 (ten years from the original date of grant).

Content

The reported transaction involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on February 11, 2019, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on February 11, 2029 (ten years from the original date of grant).